David Viskochil, MD, Ph.D.

Professor of Pediatrics
Chair, Clinical Care Advisory Board of the Children’s Tumor Foundation (national NF support organization)
Chair, Utah State Department of Health Genetic Advisory Committee
Member, Advisory Board for the Mucopolysaccharidosis I Registry
Member, Professional Advisory Board for the Tuberous Sclerosis Alliance

Division of Pediatric Genetics
Department of Pediatrics
University of Utah Health Sciences Center
Salt Lake City, UT 84132
contact address


Dr. Visckochil’s research has focused on the molecular genetics of the neurofibromatosis type 1 (NF1) gene and bone health and malignancy in patients with NF1. He performs translational research in NF1-related manifestations, and is the Utah principal investigator for the NF Clinical Trials Consortium.

Selected Bibliography:

Viskochil DH.
Neurofibromatosis Type 1.
Management of Genetic Syndromes, 3rd Edition. 2010; 549-568. New York: Wiley-Blackwell; http://www.wiley.com/WileyCDA/WileyTitle/productCd-0470191414.html
Excellent review of NF1 by an expert in the field. Book is a great resource for Medical Home providers, with chapters on 25 different genetic conditions.

Viskochil D.
Genetics of neurofibromatosis 1 and the NF1 gene.
J Child Neurol. 2002;17(8):562-70; 571-2, 646-51. PubMed abstract

Johnson BA, MacWilliams BA, Carey JC, Viskochil DH, D'Astous JL, Stevenson DA.
Motor proficiency in children with neurofibromatosis type 1.
Pediatr Phys Ther. 2010;22(4):344-8. PubMed abstract / Full Text

Thompson HL, Viskochil DH, Stevenson DA, Chapman KL.
Speech-language characteristics of children with neurofibromatosis type 1.
Am J Med Genet A. 2010;152A(2):284-90. PubMed abstract

Gottfried ON, Viskochil DH, Couldwell WT.
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Neurosurg Focus. 2010;28(1):E8. PubMed abstract